The healthcare industry has embraced GLP1 drugs as an effective way to lose weight. But the popularity of these drugs has made them tough to obtain. In a webinar last week, CEO and Co-founder…
Continue Reading
What You Should Know:
– Eli Lilly and Company (Lilly) and Amazon Pharmacy today announced a strategic collaboration to improve patient access to GLP-1 medications for diabetes, obesity, and migraines.
– The partnership aims to improve…
Continue Reading
Eli Lilly and Company has added Amazon Pharmacy as a third-party dispensing provider for LillyDirect Pharmacy Solutions, meaning the company will provide home delivery services for certain medications through LillyDirect, the companies announced Wednesday.
LillyDirect,…
Background: The success of mobile apps in improving the lifestyle of patients with non-communicable diseases through self-management interventions is contingent upon the emerging growth in this field. While users of mobile health apps continue…
Continue Reading
What You Should Know:
Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as…
Continue Reading
What You Should Know:
– Tiny Health, a pioneer in at-home gut microbiome testing for babies, announced today the successful closing of an $8.5M Series A funding round.
– Led by Spero Ventures, this round brings…
Continue Reading
Food-as-medicine companies are none too thrilled about recent comments made by Kellogg CEO Gary Pilnick.
In a CNBC interview, the multimillionaire executive encouraged families struggling to put food on the table to turn to cereal…
Omada, a virtual healthcare provider, announced Tuesday that it is expanding its GLP-1 companion solution to include musculoskeletal exercise programming and member-level reporting for employers, payers and pharmacy benefit managers.
San Francisco-based Omada serves employers,…
Background: The Health eLiteracy for Prevention in General Practice trial is a primary health care–based behavior change intervention for weight loss in Australians who are overweight and those with obesity from lower socioeconomic areas….
Continue Reading
Rob MacNaughhton, CEO at Calibrate
What You Should Know:
– Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.
– Calibrate’s strategic direction under…
Continue Reading
